Review Sperm washing techniques address the fertility needs of HIV-seropositive men: a clinical review
|
|
- Brent Richards
- 5 years ago
- Views:
Transcription
1 RBMOnline - Vol 10. No Reproductive BioMedicine Online; on web 26 November 2004 Review Sperm washing techniques address the fertility needs of HIV-seropositive men: a clinical review Dr Mark Sauer Mark Sauer is a tenured professor of Obstetrics & Gynecology at Columbia University in New York. He is Vice Chairman of the Department, and Director of the Division of Reproductive Endocrinology. He is also Program and Laboratory Director of the Center for Women s Reproductive Care, the IVF unit at the University. Since fellowship, his research interests have focused on egg and embryo donation, having developed programmes at the University of California Los Angeles (UCLA) and the University of Southern California (USC) before moving to New York in His research involving women of advanced reproductive age (40 55 years) has been instrumental in redefining fertility care in older patients, while providing insight into the importance of oocyte age on successful implantation. Mark V Sauer Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, Division of Reproductive Endocrinology, New York, NY, USA Correspondence: Centre for Women s Reproductive Care at Columbia University, 1790 Broadway, 2nd Floor, New York, NY 10019, USA. Tel: ; Fax: ; mvs9@columbia.edu Abstract It is estimated that nearly 40 million people worldwide are infected with HIV. HIV/AIDS prevalence among young people is high, with youth under age 25 years accounting for approximately half of all new infections. Nearly 1 million Americans are HIV-seropositive. Today, HIV-seropositive individuals live active and productive lives despite their illness, largely a result of prescribed highly active antiretroviral therapy (HAART). Most individuals are of reproductive age, and many desire to have children. Various assisted reproductive techniques have been used to reduce or eliminate infectious elements known to be present in semen so that isolated spermatozoa can be safely inseminated or used for intracytoplasmic sperm injection into oocytes. Presently, several European centres and a few US groups offer assistance to HIV seropositive men and their seronegative partners by performing either intrauterine insemination (IUI) or IVF. Since 1987, more than 3600 published attempts have been reported in which processed spermatozoa from HIV-seropositive men were used to establish pregnancy in HIV-seronegative women. Although the data remain observational, sperm washing techniques appear to be relatively safe and effective, offering HIV-serodiscordant couples an opportunity to have children. Keywords: HIV, IUI, IVF ICSI, serodiscordant, sperm washing Introduction It is estimated that nearly 40 million people are presently infected with HIV. Most are under the age of 25 years (UNAIDS, 2004). HIV infection occurs primarily in young, reproductively healthy individuals. The epidemic has affected hundreds of thousands of American men (CDC, 2001). Although many of these men are gay, others are engaged in heterosexual relationships and may desire children. A report of 2864 HIV-infected adults in the United States interviewed as part of the HIV Cost and Services Utilization Study confirmed this presumption, with approximately one-third of participants stating a strong desire to have children (Chen et al., 2001). However, safe sexual practices require the constant use of condoms, which reduces the risk of transmitting virus to the uninfected partner, yet also precludes any hope of pregnancy. Reproductive choices for HIV-serodiscordant couples are limited. Providing assisted reproductive care to couples in whom the male partner is known to be HIV-seropositive remains a subject of intense controversy (Anderson, 1999; Englert et al., 2001; Sauer, 2003). Donor sperm insemination and adoption represent the only recommended safe options for couples wishing to have a family. Yet, reproductive drive is very strong, and patients are known to take unreasonable risks in order to have a baby. It is therefore not surprising that HIV seroconversions of uninfected partners have occurred as a result of timed intercourse without a condom. Sperm washing and insemination techniques Sperm preparation techniques, commonly referred to as sperm washing, followed by intrauterine insemination (IUI), 135
2 has been suggested as a means of reducing the likelihood of horizontal transmission of HIV. Its clinical use in HIV infected men was first reported over a dozen years ago (Semprini et al., 1992). Although subsequent published results from Milan (Semprini et al., 1997, 1999) were encouraging, few practitioners in the United States were willing to offer IUI therapy for fear of infecting the seronegative partner and child. Early on, the Centres for Disease Control (CDC) recommended against treating HIV-serodiscordant couples following an alleged seroconversion in a woman inseminated with washed spermatozoa from her HIV-seropositive husband (CDC, 1990). That position was recently reiterated (Duerr, 2003). Renewed calls for prohibition relate more to concerns regarding the safety of sperm washing and its quality control, as well as the relative absence of long-term follow-up data on outcomes. In many locales within the United States, intentionally inseminating a woman with spermatozoa from an HIV-seropositive man constitutes a criminal act. Unfortunately, many prohibitions were based upon information regarding the natural history of HIV infection prior to 1990, a time in which the disease was typically considered to be a terminal illness. Thus, the professional, civil, and possible criminal liabilities associated with treating HIV-serodiscordant couples continue to dissuade many clinicians from providing care. Processed spermatozoa for IUI have been used in Europe, and numerous series (Table 1) document pregnancy success without HIV seroconversions (Brechard et al., 1997; Semprini et al., 1997; Vernazza et al., 1997; Marina et al., 1998; Tur et al., 1999; Bujan et al., 2001; Daudin et al., 2001; Marina, 2001; Weigel et al., 2001; Delvigne et al., 2003; Gilling-Smith et al., 2003) The large number of patients successfully treated is impressive, and these results may have influenced the American College of Obstetricians and Gynecologists (ACOG) and the American Society for Reproductive Medicine (ASRM) to revise earlier statements against caring for HIVserodiscordant couples. Both groups now recommend adopting more tolerant policies of non-discrimination (ACOG Committee Opinion, 2002; Ethics Committee of the ASRM, 2002). Separating virus from spermatozoa The basis for IUI treatment rests on the premise that isolated motile spermatozoa used in washed inseminations do not carry HIV. Spermatozoa lack the CD4 receptor and the CCR5 and CXCR4 co-receptors needed for the virus to gain entry into the host cell. Non-motile cells, particularly CD4 positive lymphocytes and macrophages, are known to exist in seminal plasma, and are principle targets for infection with HIV (Van Voorhis et al., 1991; Quayle et al., 1997). Density gradient centrifugation combined with sperm swim-up has been used in centres offering assisted reproduction for years in order to permit the intrauterine placement of spermatozoa. Washed swim-up techniques effectively separate the motile fraction of spermatozoa from the seminal plasma and non-motile cells, and have been reported to reduce HIV RNA and proviral DNA to undetectable concentrations (Kim et al., 1999; Hanabusa et al., 2000). Most practitioners of fertility care are familiar with the technique, as IUI therapy is commonly performed for the treatment of unexplained infertility. However, concerns do exist regarding the ability of a HIV surface glycoprotein (gp120) to bind to galactosyl-alkylacylglyerol (GalAAG), a glycolipid structurally related to galactosylceramide present on the surface membrane of spermatozoa (Brogi et al., 1998). This molecular complex has been associated with HIV infection in cells that lack CD4, CCR5, and CXCR4 proteins (i.e. neurons and colonic epithelium), and could potentially implicate spermatozoa as vectors of infection. This might also explain the mechanism for how HIV-like particles become associated with spermatozoa when the virus is co-cultured with gametes, as Table1. Summary of published results on HIV-1 serodiscordant couples undergoing washed sperm intrauterine inseminations. All values are numbers. Study Cycles Patients Pregnancies Births Ongoing Infection treated Semprini et al. (1997) Marina et al. (1998; 2001) Tur et al. (1999) Gilling-Smith et al. (2003) Vernazza et al. (1997) Weigel et al. (2001) Bujan et al. (2001) Daudin et al. (2001) Brechard et al. (1997) Delvigne et al. (2003) Total Cycles = attempts at treatment. Pregnancies = clinical pregnancies established, including miscarriages and ectopic pregnancies. Births = deliveries post-treatment. Ongoing = ongoing pregnancies beyond 20 weeks gestation. Infection = infections with HIV-1 resulting in seroconversions in mothers or offspring.
3 viewed by electron microscopy (Baccetti et al., 1998). However, other investigators have failed to demonstrate these relationships (Politch and Anderson, 2002; Pudney et al., 1998). HIV-1 proviral DNA or RNA has not been identified in spermatozoa taken from the highly motile fraction of processed spermatozoa (Politch et al., 2004), and it is presumed that the single case report of HIV infection resulting from an IUI (CDC, 1990) occurred as a result of contamination from non-motile cellular elements that exist in the specimen post-wash. Prior to swim-up, up to 8% of processed specimens have been noted to contain detectable HIV-RNA (Hanabusa et al., 2000). IUI or IVF There are advantages and disadvantages to both IUI and IVF approaches. Although more cases of IUI have been reported, it remains undetermined whether one approach is superior to the other in terms of safety. Intrauterine insemination is technically easier, much less expensive, and with repetitive applications approaches the efficacy of IVF in carefully selected patients. However, IUI therapy requires millions of sperm cells to be placed above the natural immunological barrier of the cervix. Catheters navigating the endocervix and endometrial cavity may create bleeding, which potentially could further increase risk. As previously mentioned, it is difficult to ensure that all CD4 positive cells are eliminated from the washed preparation. Paired semen samples obtained from HIV-seropositive men commonly express virus, even when plasma viral counts are very low (Coombs et al., 1998). Men with chronic HIV infection often have abnormal semen profiles (Pena et al., 2003a). Hypogonadism and endocrine disorders are relatively common in men with HIV (Dobs et al., 1988; Sellmeyer and Grunfeld, 1996). In other cases, men may be prescribed androgens to improve well-being and lessen muscle wasting (Bhasin et al., 2000). In such instances, the choice of IUI therapy may be questioned, since the number of procedures necessary to achieve pregnancy is greater and the overall success of IUI is generally reduced in men with persistently abnormal semen analyses (Ohl et al., 2003). Finally, as mentioned previously, several jurisdictions in the United States have regulations that prohibit insemination of HIV-infected material. Thus, although IUI therapy may be more simplistic and less expensive than IVF, and could be used in fertile couples or those with less severe fertility problems (i.e. anovulation), physicians may not be willing to inseminate women for fear of civil or criminal liability. Intracytoplasmic sperm injection (ICSI) has commonly been used to address male factor infertility and is available at most centres providing assisted reproduction. Similar to preparing spermatozoa for IUI, discontinuous density gradient centrifugation techniques are used prior to ICSI and only the resultant motile spermatozoa found in the supernatant following swim-up are selected. Typically, fewer than 20 spermatozoa are injected per case of IVF ICSI, compared with tens of millions inseminated during an IUI. Furthermore, since IVF ICSI represents a mechanical means to fertilize oocytes, it may be argued that insemination is not performed. This may be helpful in locations where laws prohibit insemination procedures. Thus, IVF ICSI represents another alternative to reduce the risk of horizontal transmission of HIV. However, IVF ICSI is associated with high cost, and has its own unique risks and complications. Therefore, patients choosing this technique must be aware of the increased incidence of multiple births and ovarian hyperstimulation syndrome reported in serodiscordant couples undertaking IVF ICSI (Pena et al., 2003b). The published results from clinical studies utilizing IVF or IVF ICSI are reviewed and summarized in Table 2. (Semprini et al., 1999; Semprini, 2000; Journet et al., 2001; Loutradis et al., 2001; Weigel et al., 2001; Delvigne et al., 2003; Gilling- Smith et al., 2003; Marina et al., 2003; Ohl et al., 2003; Pena et al., 2003c; Morshedi et al., 2003). Table 2. Summary of published results on IVF or IVF ICSI in HIV-1 serodiscordant couples. All values are numbers. Study Cycles Patients Pregnancies Births Ongoing Infection treated Semprini et al. (1999, 2000) Gilling-Smith et al. (2003) Weigel et al. (2001) Delvigne et al. (2003) Total IVF ICSI therapy Marina et al. (2003) Weigel et al. (2001) Jonannet et al. (2001) Loutradis et al. (2001) Ohl et al. (2003) Pena et al. (2003) Morshedi et al. (2003) Gilling-Smith et al. (2003) Total See Table 1 for definitions of parameters. 137
4 Establishing a programme for treatment In 1997, the Ethics Committee of Columbia Presbyterian Medical Centre first considered and granted a request to allow HIV-serodiscordant couples access to assisted reproductive care (Sauer, 2003). A protocol was next approved by the Institutional Review Board of the medical centre, allowing a study of safety and treatment efficacy (Sauer and Chang, 2002). Enrolled subjects were under active medical surveillance for their HIV illness by infectious disease specialists in internal medicine and where appropriate, they were prescribed antiviral medications. Plasma HIV RNA viral counts and CD4 status were ascertained. Men were infected through a variety of ways, including transfusion therapy, sex and intravenous drug use. Female partners were HIV tested and required to be seronegative. Couples stated that they were using condoms and practicing safe sex. Women underwent thorough pelvic examinations including PAP smears and cervical cultures, and serum oestradiol and follicle stimulating hormone concentrations were drawn to evaluate the appropriateness of IVF therapy. Table 3 profiles the first 50 consecutive couples entering the programme and tallies their attitudes regarding various ways of having a child together (Klein et al., 2003). IVF ICSI and follow-up Standard pre-cycle procedures routinely used in assisted reproduction were provided. Needle aspiration of the oocytes was timed h following human chorionic gonadotrophin (HCG) injection. A fresh semen sample was used for ICSI and processed by centrifuging it through a discontinuous density gradient. After centrifugation of the gradient tubes, the pellet was resuspended in human tubal fluid (HTF), washed and again suspended in HTF. The specimen was then subjected to a final swim-up procedure in order to recover the most motile fraction for use in ICSI. Semen preparation was performed using a class II biological hood located in a separate laboratory outside of embryology. Following swim-up, the purified specimen was brought into the IVF ICSI suite for use. Ultrasound guided transcervical embryo transfers at 72 h occurred in all cases. Patients were tested for pregnancy 12 days following transfer. Serial blood testing (HIV-proviral DNA or ultrasensitive HIV-RNA polymerase chain reaction; PCR) was repeated throughout each trimester of pregnancy. At delivery and 3 months postpartum, mothers were again tested using HIV-DNA or HIV- RNA PCR, sensitive enough to detect virus down to the level of <50 copies/ml blood. Newborns were also tested at birth and 3 months age. Patients failing to become pregnant or women who experienced spontaneous abortion were asked to repeat their HIV tests 3 and 6 months later. Results during the initial 5 years In preliminary published experience (Sauer, 2002) with IVF ICSI there were no seroconversions in women (n = 34) or offspring (n = 25) following 55 embryo transfers. Treatment efficacy was similar to normal controls undergoing IVF ICSI for the treatment of male factor infertility. Most pregnancies occurred within the first three attempts at IVF ICSI. Half (17/34) of all couples making it to retrieval successfully achieved a viable pregnancy. There were no seroconversions in any of the 34 patients receiving one or more of the 55 embryo transfers. All 25 delivered infants were HIV negative at birth and at 3 months of age. A follow-up series of over 100 attempts noted similar results (Pena et al., 2003c). Table 4 describes the clinical outcomes. Again, pregnancies typically occurred within 3 cycles of treatment, with cumulative pregnancy rates per couple greater than 50%. Not all serodiscordant couples have performed well, however, as patients who are poor responders to ovarian stimulation and women over 40 years of age have not produced as many pregnancies as younger patients. Therefore, couples with fertility problems that are associated with poor IVF success rates should be made aware of the financial costs of care and the low success rate of treatment given the unknown risk of HIV transmission Table 3. Demographic characterization of HIV-1 serodiscordant couples interested in assisted reproductive care. Profile of 50 consecutive couples (Klein et al., 2003). Figures in parentheses are percentages. Age of men (years; mean ± SD) 38.0 ± 6 (range 26 51) Age of women (years; mean ± SD) 34.5 ± 5 (range 24 45) Married 4/50 (88) Duration of relationship (years; mean ± SD) 9.0 ± 5 (range 1 20) Couples with child together prior to presentation 9/50 (18) Children conceived after knowing HIV status 3/9 (33) Couples attempting timed intercourse to conceive 4/50 (8) Couples preferring donor sperm to timed intercourse 24/50 (48) Favour posthumous attempts to conceive if partner died 22/50 (44) Couples discussed single parenting risk 45/50 (90) Couples discussed adoption of child if both parents died 29/50 (58) Couples desiring to have multiple children through assisted reproduction 33/50 (66) Couples willing to discuss experience with other discordant couples 36/50 (72) 138
5 Table 4. Clinical results of the first 113 consecutive treatment attempts using IVF ICSI in HIV-1 serodiscordant couples (Pena et al., 2003). No. of couples treated 61 No. of initiated cycles 113 No. attempts per couple a 1.9 ± 1.1 (1 6) Cancellation rate due to poor ovarian response (%) 11.5 No. oocytes aspirated per retrieval a 17.1 ± 9.5 (2 47) No. mature oocytes suitable for ICSI a 13.9 ± 8.1 (1 42) No. fertilized oocytes per ICSI case a 9.3 ± 5.5 (0 24) No. embryos transferred per attempt a 3.5 ± 1.1 (1 6) Couples with cryopreserved embryos (%) 32.2 No. embryos cryopreserved per couple a 5.1 ± 3.5 (1 19) Overall clinical pregnancy rate per embryo transfer (%) 44.8 Ongoing and delivered pregnancy rate per embryo transfer (%) 36.5 Cumulative pregnancy rate for couples over repeated attempts (%) 54.1 No. of seroconversions in treated women 0 No. of seroconversions in delivered offspring 0 a Values are mean ± SD (range). that accompanies IVF ICSI. Although controversial, oocyte donation may be yet another alternative to allow couples at high risk for IVF failure the opportunity for pregnancy with their husbands spermatozoa (Pena et al., 2003d). Conclusions The purpose of all clinical trials involving various sperm separation techniques is to provide HIV-serodiscordant couples an opportunity to have a child without risk of viral transmission. Both IUI and IVF have been suggested as preventive measures to avoid infection in HIVserodiscordant couples intent on reproducing. It remains undetermined as to whether one procedure is superior to the other with respect to both safety and efficacy. The commonly accepted principles of health care ethics include consideration of respect for autonomy, nonmaleficence, beneficence, fidelity and justice (Beauchamp and Childress, 1994; Sauer, 2003). Each of these tenets should be individually considered in making a decision to treat. Informed and rationale decision-making must occur in every case of intervention. A lengthy discussion of the natural history of HIV infection, and the biology of transmission should precede attempts at treatment. Reproductive alternatives, including artificial insemination with donor spermatozoa, adoption, and childless living should also be offered, as not all patients will choose sperm preparation techniques once cognizant of the potential danger for infection. It is important to engage patients in a frank dialog with respect to the investigational nature of this form of treatment while providing them enough information to exercise informed consent. It is essential to safeguard the patient s right to act intentionally and without controlling influences. Most importantly, participants need to understand that no procedure is risk free, as all carry a possibility for transmitting infection. References Anderson DJ 1999 Assisted reproduction for couples infected with the human immunodeficiency virus type 1. Fertility and Sterility 72, Bacetti B, Benedetto A, Collodel G et al The debate on the presence of HIV-1 in human gametes. Journal of Reproductive Immunology 41, Beauchamp T, Childress J 1994 Principles of Biomedical Ethics, 4th edition. Oxford University Press, New York. Bhasin S, Storer TW, Javanbakht M et al Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels. Journal of the American Medical Association 283, Brechard N, Galea P, Silvy F, Amram M et al Etude de la localization du VIH dans le sperme. Contraception Fertility and Sexuality 25, Brogi A, Presentini R, Moretti E et al New insights into the interaction between the gp120 and the HIV receptor in human sperm. Journal of Reproductive Immunology 41, Bujan L 2001 Reproduction, laboratory and HIV-1. Fourth International Symposium on AIDS and Reproduction, Genoa. Centers for Disease Control 1990 Epidemiologic notes and reports. HIV-1 infection and artificial insemination with processed semen. MMWR Morbidity Mortality Weekly Report 249, Centers for Disease Control and Prevention 2001 HIV/AIDS Surveillance Report. CDC and Prevention, Atlanta, 13, Chen JL, Phillips KA, Kanouse DE et al Fertility desires and intentions of HIV-positive men and women. Family Planning Perspectives 33, Committee on Ethics of the American College of Obstetricians and Gynecologists (ACOG) 2002 Ethics in Obstetrics and Gynecology, ACOG, Washington, D.C., pp Coombs RW, Speck CE, Hughes JE et al Association between culturable human immunodeficiency virus type 1 in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood. Journal of Infectious Disease 177, Daudin M, Pasquier C, Izopet J et al Le Protocole ANRS 096: prise en charge en assistance medicale a la procreation des couples serodifferents don t l homme est infecte par le VIH. Reproduction Human Hormones 14, Delvigne A, Barlow P, Manigart Y et al Fertility treatment in 139
6 140 couples where either or both partners are HIV infected. Human Reproduction 18 (Suppl. 1), xviii137 (abstr. P-405). Dobs AS, Dempsey MA, Ladenson PW et al Endocrine disorders in men infected with human immunodeficiency virus. American Journal of Medicine 84, Duerr A 2003 Assisted reproductive technologies for discordant couples. American Journal of Bioethics 3, Englert Y, Van Vooren JP, Place I et al ART in HIV-infected couples. Has the time come for a change in attitude? Human Reproduction 16, Ethics Committee of the ASRM 2002 HIV and infertility treatment. Fertility and Sterility 77, Gilling-Smith C, Frodsham LCG, Tamberlin B et al Reducing reproductive risks in HIV infected couples: a comprehensive programme of care. Human Reproduction 18 (Suppl. 1), xviii. Hanabusa H, Kuji N, Kato S et al An evaluation of semen processing methods for eliminating HIV-1. AIDS 14, Jounnet P 2001 Reproductive Medicine in the 21st Century. Parthenon, London. Kim LU, Johnson MR, Barton S et al Evaluation of sperm washing as a potential method of reducing HIV-transmission in HIV-discordant couples wishing to have children. AIDS 13, Klein J, Pena J, Thornton MH et al Understanding the motivations, concerns, and desires of HIV-serodiscordant couples wishing to have children through assisted reproduction. Obstetrics and Gynecology 10, Loutradis E, Drakakis P, Kalianidis K et al Birth of 2 infants who were seronegative for human immunodeficiency virus type 1 after intracytoplasmic injection of sperm from HIV-1 seropositive men. Fertility and Sterility 75, Marina S 2001 Round table discussion. Fourth International Symposium on AIDS and Reproduction, Genoa. Marina S, Marina F, Alcolea R et al Human immunodeficiency virus type 1-serodiscordant couples can bear healthy children after undergoing intrauterine insemination. Fertility and Sterility 70, Marina S, Semprini AE, Marina F et al Results of 219 IVF- ICSI cycles in serodiscordant couples (seropositive men) to HIV- 1. Human Reproduction 18 (suppl. 1), xviii152 (abstr. P-450). Morshedi M, Bocca S, Diaz J et al Assisted conception in serodiscordant couples in whom the man is HIV(+) using a strict protocol for semen processing and testing. Fertility and Sterility 80 (suppl. 3), S40. Ohl J, Partisani M, Wittemer C et al Assisted reproduction techniques for HIV serodiscordant couples: 18 months experience. Human Reproduction 18, Pena JE, Thornton MH, Sauer MV 2003a Reversible azospermia: anabolic steroids may profoundly affect HIV seropositive men undergoing assisted reproduction. Obstetrics and Gynecology 101, Pena JE, Thornton MH, Sauer MV 2003b Complications of IVF ICSI in HIV-serodiscordant couples. Archives of Gynecology and Obstetrics 268, Pena JE, Thornton MH, Sauer MV 2003c In-vitro fertilization with intracytoplasmic sperm injection to prevent viral transmission in HIV-1 serodiscordant couples: report of 113 consecutive cycles. Fertility and Sterility 80, Pena JE, Thornton MH, Ruman J et al. 2003d Oocyte donation to HIV-1 serodiscordant couples failing IVF ICSI: preliminary experience. Archives of Gynecology and Obstetrics 268, Politch JA, Anderson DJ 2002 Preventing HIV-1 infection in women. Infertility and Reproductive Medicine Clinics of North America 13, Politch J, Xu C, Tucker L et al Separation of human immunodeficiency virus type 1 from motile sperm by the double tube gradient method versus other methods. Fertility and Sterility 81, Pudney J, Nguyen H, Xu C et al Microscopic evidence against HIV-1 infection of germ cells or attachment to spermatozoa. Journal of Reproductive Immunology 41, Quayle AJ, Xu C, Mayer KH et al T lymphocytes and macrophages but not motile spermatozoa, are a significant source of HIV in semen. Journal of Infectious Disease 176, Sauer MV 2003 Providing assisted reproductive care to HIVserodiscordant couples: time to reexamine healthcare policy. American Journal of Bioethics 3, Sauer MV, Chang PL 2002 Establishing a clinical program for HIV-1 seropositive males to father healthy children using IVF-ICSI. American Journal of Obstetrics and Gynecology 186, Sellmeyer DE, Grunfeld C 1996 Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Endocrine Reviews 17, Semprini AE 2000 Viral transmission in ART: risks for patients and healthcare providers. Human Reproduction 15, 69. Semprini AE, Levi-Setti P, Bozzo M et al Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet 340, Semprini AE, Fiore S, Pardi G 1997 Reproductive counselling for HIV-discordant couples. Lancet 349, Semprini AE, Vucetich A, Oneta M et al IVF-ET with processed sperm of HIV-positive males in infertile HIVdiscordant couples. Fertility and Sterility 72, S40. Tur R, Veiga A, Busquets A et al Artificial insemination with processed sperm samples from serodiscordant couples for HIV-1. Human Reproduction 14, 208. UNIAIDS 2004 Report on the Global AIDS Epidemic. July Van Voorhis B, Martinez A, Mayer K et al Detection of human immunodeficiency virus type 1 in semen from seropositive men using culture and polymerase chain reaction deoxyribonucleic acid amplification techniques. Fertility and Sterility 55, Vernazza PL, Gilliam BL, Dyer J et al Quantification of HIV in semen: Correlation with antiviral treatment and immune status. AIDS 11, Weigel M, Gentilli M, Beichart M et al Reproductive assistance to HIV-discordant couples the German approach. European Journal Medical Research 6, Received 7 September 2004; refereed 12 October 2004; accepted 18 November 2004.
Article Assessing the treatment efficacy of IVF with intracytoplasmic sperm injection in human immunodeficiency virus-1 (HIV-1) serodiscordant couples
RBMOnline - Vol 10. No 1. 2005 130-134 Reproductive BioMedicine Online; www.rbmonline.com/article/1509 on web 29 September 2004 Article Assessing the treatment efficacy of IVF with intracytoplasmic sperm
More informationAdoption and Foster Care
GLOSSARY Family building via Adoption and Foster Care October 2018 www.familyequality.org/resources A Anonymous Donor: A person who donated sperm or eggs with the intention of never meeting resulting children.
More informationFertility Desires/Management of Serodiscordant HIV + Couples
Fertility Desires/Management of Serodiscordant HIV + Couples William R. Short, MD, MPH Assistant Professor of Medicine Division Of Infectious Diseases Jefferson Medical College of Thomas Jefferson University
More informationCharacteristic profiles of HIV-serodiscordant couples. N (%) Mean ± SEM Range
Providing fertility care to men seropositive for human immunodeficiency virus: reviewing 10 years of experience and 420 consecutive cycles of in vitro fertilization and intracytoplasmic sperm injection
More informationHIV Reproductive Health: Conception Options in the Era of PrEP
HIV Reproductive Health: Conception Options in the Era of PrEP Meg Sullivan, MD Director, HIV Clinical Programs, Section of Infectious Diseases Boston Medical Center Boston University School of Medicine
More informationComment diminuer le risque de transmission pour les couples séro-différents (VIH et/ou VHC)?
Risque viral et procréation Comment diminuer le risque de transmission pour les couples séro-différents (VIH et/ou VHC)? Pr Ch. PASQUIER Laboratoire de Virologie, CHU Toulouse, France JNI 8/06/2005 Evidence
More informationPROCEDURES LAPAROSCOPY
PROCEDURES - Further infertility work-up if indicated (ultrasound examination / semen decontamination etc.) - Office Hysteroscopy where indicated - Laparoscopic and /or hysteroscopic surgery where indicated
More informationClinical Policy Committee
Northern, Eastern and Western Devon Clinical Commissioning Group South Devon and Torbay Clinical Commissioning Group Clinical Policy Committee Commissioning policy: Assisted Conception Fertility treatments
More informationTreating Infertility
Treating Infertility WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 About 10% of couples in the United States are infertile. Infertility is a condition in which a woman has not been able
More informationClinical Policy Committee
Clinical Policy Committee Commissioning policy: Assisted Conception Fertility assessment and investigations are commissioned where: A woman is of reproductive age and has not conceived after one (1) year
More informationJoseph E. Peña, M.D., Melvin H. Thornton II, M.D., and Mark V. Sauer, M.D.
FERTILITY AND STERILITY VOL. 80, NO. 2, AUGUST 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Assessing the clinical utility
More informationAddressing the Fertility Needs of HIV-Seropositive Males
Sacred Heart University DigitalCommons@SHU Psychology Faculty Publications Psychology Department 2011 Addressing the Fertility Needs of HIV-Seropositive Males Brian A. Levine Columbia University Sahadat
More informationInfertility treatment
In the name of God Infertility treatment Treatment options The optimal treatment is one that provide an acceptable success rate, has minimal risk and is costeffective. The treatment options are: 1- Ovulation
More informationArticle A systematic, multidisciplinary approach to address the reproductive needs of HIVseropositive
RBMOnline - Vol 19 No 2. 2009 257-263 Reproductive BioMedicine Online; www.rbmonline.com/article/3785 on web 15 May 2009 Article A systematic, multidisciplinary approach to address the reproductive needs
More informationJ Formos Med Assoc 2011;110(8): Contents lists available at ScienceDirect. Journal of the Formosan Medical Association
Volume 110 Number 8 August 2011 Formosan Medical Association Taipei, Taiwan ISSN 0929 6646 Resveratrol for prophylaxis of ischemic stroke Microglia and chronic pain ART in HIV-1-discordant couples in Taiwan
More informationWHAT IS A PATIENT CARE ADVOCATE?
WHAT IS A PATIENT CARE ADVOCATE? Fertility treatments can be overwhelming. As a member, you have unlimited access to a dedicated Patient Care Advocate (PCA), who acts as your expert resource for discussing
More informationNICE fertility guidelines. Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic
NICE fertility guidelines Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic About the LWC 4 centres around the UK London Cardiff Swansea Darlington The largest sperm bank in
More informationSt Helens CCG NHS Funded Treatment for Subfertility Policy 2015/16
St Helens CCG NHS Funded Treatment for Subfertility Policy 2015/16 1 Standard Operating Procedure St Helens CCG NHS Funded Treatment for Sub Fertility Policy Version 1 Implementation Date May 2015 Review
More informationThey are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest
More informationBlackpool CCG. Policies for the Commissioning of Healthcare. Assisted Conception
1 Introduction Blackpool CCG Policies for the Commissioning of Healthcare Assisted Conception 1.1 This policy describes circumstances in which NHS Blackpool Clinical Commissioning Group (CCG) will fund
More informationFertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.
Dr. Shahin Ghadir A Primary Care Approach to Diagnosing and Treating Infertility St. Charles Bend Grand Rounds November 30, 2018 I have no conflicts of interest to disclose. + About SCRC State-of-the-art
More informationFamily Building for Transgender Men and Women
Family Building for Transgender Men and Women A Guide to Becoming a Parent PATH2PARENTHOOD path2parenthood.org Are you a transgender man or woman and think you might want to become a parent? If you re
More informationFertility Therapy for Women & their Partners Affected by HIV. J. Preston Parry, MD, MPH
Fertility Therapy for Women & their Partners Affected by HIV J. Preston Parry, MD, MPH Objectives To recognize historical barriers to care for women and their partners affected by HIV To understand evidence
More informationConsent for In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and Embryo Cryopreservation/Disposition
Consent for In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and Embryo Cryopreservation/Disposition Patient Name (please print) Patient DOB (MM/DD/YYYY) Patient eivf number Partner
More informationFertility Policy. December Introduction
Fertility Policy December 2015 Introduction Camden Clinical Commissioning Group (CCG) is responsible for commissioning a range of health services including hospital, mental health and community services
More informationNHS FUNDED TREATMENT FOR SUBFERTILITY. ELIGIBILITY CRITERIA POLICY GUIDANCE/OPTIONS FOR CCGs
NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA POLICY GUIDANCE/OPTIONS FOR CCGs CONTENTS Page 1. INTRODUCTION 2 2. GENERAL PRINCIPLES 2 3. DEFINITION OF SUBFERTILITY AND TIMING OF ACCESS TO
More informationWiltshire CCG Fertility Policy
Wiltshire CCG Fertility Policy Introduction This policy sets out the limits within which WCCG will fund treatment with either Intrauterine Insemination [IUI], ovulation induction medication or donor insemination
More informationWOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IN VITRO FERTILIZATION USING A GESTATIONAL CARRIER (PATIENT/INTENDED PARENTS) 1.
*40675* 40675 MR-838 (9-2017) WOMEN & INFANTS HOSPITAL Providence, RI 02905 CONSENT FOR IN VITRO FERTILIZATION USING A GESTATIONAL CARRIER (PATIENT/INTENDED PARENTS) 1. I, and (Print Patient s name) (Print
More informationDREAMS TO REALITY. Family Building for Men and Women Living with HIV PATH2PARENTHOOD. path2parenthood.org/hiv
DREAMS TO REALITY Family Building for Men and Women Living with HIV PATH2PARENTHOOD path2parenthood.org/hiv ARE YOU HIV POSITIVE, YET DREAM OF HAVING A FAMILY? If you are reading this handbook, you may
More informationThe Gay Woman s Guide to Becoming a Mom PATH2PARENTHOOD. path2parenthood.org
The Gay Woman s Guide to Becoming a Mom PATH2PARENTHOOD path2parenthood.org For lesbians, there are a number of viable routes that can be considered when achieving motherhood is the goal. Whether you are
More informationDRAFT Policy for the Provision of NHS funded Gamete Retrieval and Cryopreservation for the Preservation of Fertility
NHS Birmingham and Solihull Clinical Commissioning Group NHS Sandwell and West Birmingham Clinical Commissioning Group DRAFT Policy for the Provision of NHS funded Gamete Retrieval and Cryopreservation
More informationIVF. NHS North West London CCGs
IVF NHS North West London CCGs Commissioning Policy for In Vitro Fertilisation (IVF)/ Intracytoplasmic Sperm Injection (ICSI) within tertiary Infertility Services Adopted by NWL CCGs to be effective from
More informationEast and North Hertfordshire CCG. Fertility treatment and referral criteria for tertiary level assisted conception
East and North Hertfordshire CCG Fertility treatment and referral criteria for tertiary level assisted conception December 2015 1 1. Introduction This policy sets out the entitlement and service that will
More informationBrighton & Hove CCG PLS CONFERENCE Dr Carole Gilling-Smith Medical Director
Brighton & Hove CCG PLS CONFERENCE 2016 Dr Carole Gilling-Smith Medical Director FERTILITY CHALLENGES IN THE NHS A TERTIARY CARE PERSPECTIVE LEARNING OBJECTIVES Understand the pathways through assisted
More informationHALTON CLINICAL COMMISSIONING GROUP NHS FUNDED TREATMENT FOR SUBFERTILITY. CONTENTS Page
HALTON CLINICAL COMMISSIONING GROUP NHS FUNDED TREATMENT FOR SUBFERTILITY CONTENTS Page 1. INTRODUCTION 2 2. GENERAL PRINCIPLES 2 3. DEFINITION OF SUBFERTILITY AND TIMING OF ACCESS TO TREATMENT 3 4. DEFINITION
More informationAccess to IVF. Help us decide Discussion paper. South Central Specialised Commissioning Group C - 1
Access to IVF Help us decide Discussion paper South Central Specialised Commissioning Group 1 C - 1 Access to IVF treatment Contents 1. Background 3 2. Developing a single policy for NHS South Central..4
More informationReversible Conditions Organising More Information semen analysis Male Infertility at Melbourne IVF Fertility Preservation
Male Infertility Understanding fertility in men Conceiving a baby depends on a number of factors, including healthy sperm. After a woman s age, this can be the biggest issue. Reproduction, although simple
More informationFertility treatment and referral criteria for tertiary level assisted conception
Fertility treatment and referral criteria for tertiary level assisted conception Version Number Name of Originator/Author Cross Reference V2 East of England Consortium Commissioning Policy for Fertility
More informationReproductive Technology, Genetic Testing, and Gene Therapy
Michael Cummings Chapter 16 Reproductive Technology, Genetic Testing, and Gene Therapy David Reisman University of South Carolina 16.1 Infertility Is a Common Problem In the US, about 13% of all couples
More informationWOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IVF WITH EMBRYO TRANSFER
*40639* 40639 WOMEN & INFANTS HOSPITAL Providence, RI 02905 CONSENT FOR IVF WITH EMBRYO TRANSFER I have requested treatment by the physicians and (Print Patient s name) staff of the Women & Infants Fertility
More informationASSISTED CONCEPTION NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA & POLICY GUIDANCE
ASSISTED CONCEPTION NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA & POLICY GUIDANCE Version 1.0 Page 1 of 11 MARCH 2014 POLICY DOCUMENT VERSION CONTROL CERTIFICATE TITLE Title: Assisted Conception
More informationInformation Booklet. Exploring the causes of infertility and treatment options.
Information Booklet Exploring the causes of infertility and treatment options www.ptafertility.co.za info@ptafertility.co.za +27 12 998 8854 Faith is taking the first step even if you don t see the whole
More informationINDICATIONS OF IVF/ICSI
PROCESS OF IVF/ICSI INDICATIONS OF IVF/ICSI IVF is most clearly indicated when infertility results from one or more causes having no other effective treatment; Tubal disease. In women with blocked fallopian
More informationCOMMISSIONING POLICY. Tertiary treatment for assisted conception services
Final Version COMMISSIONING POLICY Tertiary treatment for assisted conception services Designated providers for patients registered with a Worcestershire GP BMI The Priory Hospital, Birmingham - 1 - Commissioning
More informationRealizing dreams booklet.indd 1 5/20/ :26:52 AM
Realizing dreams. 18891booklet.indd 1 5/20/2010 11:26:52 AM The Journey To Parenthood The first Gator Baby was born in 1988 through the in vitro fertilization program at the University of Florida. Since
More informationPolicy updated: November 2018 (approved by Haringey and Islington s Executive Management Team on 5 December 2018)
Islington CCG Fertility Policy First approved: 29 January 2015 Policy updated: November 2018 (approved by Haringey and Islington s Executive Management Team on 5 December 2018) Introduction Islington CCG
More informationApproved January Waltham Forest CCG Fertility policy
Approved January 2015 Waltham Forest CCG Fertility policy Contents 1 Introduction 1 2 Individual Funding Requests 1 2.1 Eligibility criteria 1 2.2 Number of cycles funded 2 2.3 Treatment Pathway 3 Page
More informationHaringey CCG Fertility Policy April 2014
Haringey CCG Fertility Policy April 2014 1 SUMMARY This policy describes the clinical pathways and entry criteria for Haringey patients wishing to access NHS funded fertility treatment. 2 RESPONSIBLE PERSON:
More informationInfertility F REQUENTLY A SKED Q UESTIONS. Q: Is infertility a common problem?
Infertility (female factors). In another one third of cases, infertility is due to the man (male factors). The remaining cases are caused by a mixture of male and female factors or by unknown factors.
More informationHIV and women having children
HIV and women having children 1. Introduction 2. How HIV is spread 3. Planning a family 4. HIV positive women and conception 5. HIV positive men and conception 6. Pregnancy issues for HIV positive women
More informationFertility treatment and referral criteria for tertiary level assisted conception
Fertility treatment and referral criteria for tertiary level assisted conception Version Number 2.0 Ratified by HVCCG Exec Team Date Ratified 9 th November 2017 Name of Originator/Author Dr Raj Nagaraj
More informationRecommended Interim Policy Statement 150: Assisted Conception Services
Southampton City Clinical Commissioning Group (CCG) took on commissioning responsibility for Assisted Conception Services from 1 April 2013 for its population and agreed to adopt the interim policy recommendations
More informationHIV: Pregnancy in Serodiscordant Couple. Dr Chow TS ID Clinic HPP
HIV: Pregnancy in Serodiscordant Couple Dr Chow TS ID Clinic HPP Sexual Reproductive Health and Rights The recognition of the sexual and reproductive health and rights (SRHR) of all individuals and couples
More informationUnderstanding IVF Processes in Surrogacy
Melvin H. Thornton II MD Medical Director CT Fertility Understanding IVF Processes in Surrogacy The Basics Surrogacy involves multiple parties IVF CLINIC Egg donors screening and matching* Medical process
More informationTestosterone Therapy-Male Infertility
Testosterone Therapy-Male Infertility Testosterone Therapy-Male Infertility Many men are prescribed testosterone for a variety of reasons. Low testosterone levels (Low T) with no symptoms, general symptoms
More informationBiology of fertility control. Higher Human Biology
Biology of fertility control Higher Human Biology Learning Intention Compare fertile periods in females and males What is infertility? Infertility is the inability of a sexually active, non-contracepting
More informationGetting Help for Obstructive Azoospermia A BASIC GUIDE TO MALE. A doctor s guide for patients developed by the American Urological Association, Inc.
A BASIC GUIDE TO MALE Getting Help for Obstructive Azoospermia A doctor s guide for patients developed by the American Urological Association, Inc. Based on the AUA Best Practice Policy and ASRM Practice
More informationPolicy statement. Commissioning of Fertility treatments
Policy statement Commissioning of Fertility treatments NB: The policy relating to commissioning of fertility treatments is unchanged from the version approved by the CCG in March 2017. The clinical thresholds
More informationHUMAN PAPILLOMAVIRUS. About Human papillomavirus
HUMAN PAPILLOMAVIRUS Hpv A common virus that affects both males and females that could result in genital warts or cancer. Diagnosis Male & Female About Human papillomavirus Human papillomavirus, or HPV,
More informationIntrauterine Insemination - FAQs Q. How Does Pregnancy Occur?
Published on: 8 Apr 2013 Intrauterine Insemination - FAQs Q. How Does Pregnancy Occur? A. The female reproductive system involves the uterus, ovaries, fallopian tubes, cervix and vagina. The female hormones,
More informationNote: This updated policy supersedes all previous fertility policies and reflects changes agreed by BHR CCGs governing bodies in June 2017.
Fertility Policy 10 July 2017 Note: This updated policy supersedes all previous fertility policies and reflects changes agreed by BHR CCGs governing bodies in June 2017. Introduction BHR CCGs are responsible
More informationHepatitis C: what do you need to know if trying to conceive
Hepatitis C: what do you need to know if trying to conceive Hepatitis C: what do you need to know if trying to conceive Hepatitis C Infection Hepatitis C Virus (HCV) infects 3% of the world s population.
More informationSafety of sperm washing and ART outcome in 741 HIV-1-serodiscordant couples
Human Reproduction Vol.22, No.3 pp. 772 777, 2007 Advance Access publication November 15, 2006. doi:10.1093/humrep/del422 Safety of sperm washing and ART outcome in 741 HIV-1-serodiscordant couples V.Savasi
More informationIui Intrauterine Insemination
Iui Intrauterine Insemination 1 / 6 2 / 6 3 / 6 Iui Intrauterine Insemination IUI, intrauterine insemination is a fertility procedure with success rates depending on female age, sperm numbers and any tubal
More informationBonnie Steinbock University at Albany (emerita) Distinguished Visiting Professor, CUHK Centre for Bioethics 12th December, 2015
Bonnie Steinbock University at Albany (emerita) Distinguished Visiting Professor, CUHK Centre for Bioethics 12th December, 2015 Defined as inability to get pregnant after a year of regular sexual intercourse
More informationFertility Management in HIV. INTEREST Workshop, 16 Dakar May 2013 Vivian Black, Director Clinical Programmes Wits Reproductive Health & HIV Institute
Fertility Management in HIV INTEREST Workshop, 16 Dakar May 2013 Vivian Black, Director Clinical Programmes Wits Reproductive Health & HIV Institute What to consider Does HIV affect fertility success?
More informationDirector of Commissioning, Telford and Wrekin CCG and Shropshire CCG. Version No. Approval Date August 2015 Review Date August 2017
Commissioning Policy for In Vitro Fertilisation (IVF)/ Intracytoplasmic Sperm Injection (ICSI) within tertiary Infertility Services, in Shropshire and Telford and Wrekin Owner(s) Version No. Director of
More informationSHIP8 Clinical Commissioning Groups Priorities Committee (Southampton, Hampshire, Isle of Wight and Portsmouth CCGs)
SHIP8 Clinical Commissioning Groups Priorities Committee (Southampton, Hampshire, Isle of Wight and Portsmouth CCGs) Policy Recommendation 002: Assisted Conception Services Date of Issue: September 2014
More informationEuropean IVF Monitoring (EIM) Year: 2013
European IVF Monitoring (EIM) Year: 2013 Name of the country Poland Name and full address of the contact person. Anna Janicka, PhD Polish Society of Reproductive Medicine and Embryology Fertility and Sterility
More informationWhat to do about infertility?
What to do about infertility? Dr. M.A. Fischer Section Head, Division of Urology, Department of Surgery Assistant Clinical Professor, Department of Obstetrics and Gynecology Hamilton Health Sciences, Hamilton,
More informationNorth Staffordshire Clinical Commissioning Group. Infertility and Assisted Reproduction Commissioning Policy and Eligibility Criteria
North Staffordshire Clinical Commissioning Group Infertility and Assisted Reproduction Commissioning Policy and Eligibility Criteria Policy Infertility and Assisted Reproduction Commissioning Policy and
More informationAssisted reproductive technologies to establish pregnancies in couples with an HIV-1-infected man
REVIEW Assisted reproductive technologies to establish pregnancies in couples with an HIV-1-infected man E. van Leeuwen 1,2*, S. Repping 1, J.M. Prins 2, P. Reiss 2,3, F. van der Veen 1 1 Centre for Reproductive
More informationRelation between the Number and Size of Follicles in Ovulation Induction and the Rate of Pregnancy
Relation between the Number and Size of Follicles in Ovulation Induction and the Rate of Pregnancy Aseel Mosa Jabber M.SC.G.O. The department of Obstetrics and Gynecology, Faculty of Medicine Thi-qar university
More informationWest Hampshire Clinical Commissioning Group Board
West Hampshire Clinical Commissioning Group Board Date of meeting 25 July 2013 Agenda Item 9 Paper No WHCCG13/089 Priorities Committee Statement Assisted Conception/IVF Key issues An Interim Policy Statement
More informationInfertility. Thomas Lloyd and Samera Dean
Infertility Thomas Lloyd and Samera Dean Infertility Definition Causes Referral criteria Assisted reproductive techniques Complications Ethics What is infertility? Woman Reproductive age Has not conceived
More informationPolicy statement. Fertility treatments. This policy is unchanged from the version approved by the CCG in July 2014.
Policy statement Fertility treatments This policy is unchanged from the version approved by the CCG in July 2014. Title Policy statement: Fertility treatments v2.0 Author Jacky Walters Approved by Kingston
More informationIntrauterine (IUI) and Donor Insemination (DI) Policy (excluding In vitro fertilisation (IVF) & Intracytoplasmic sperm injection (ICSI) treatment)
Leicester City Clinical Commissioning Group West Leicestershire Clinical Commissioning Group East Leicestershire and Rutland Clinical Commissioning Group POLICY DOCUMENT Intrauterine (IUI) and Donor Insemination
More informationThe Latest on HIV Testing. Dominika Seidman, MD MAS
The Latest on HIV Testing Dominika Seidman, MD MAS Disclosures none 2 Learning objectives At the conclusion of this session, participants should be able to Define the window periods for various HIV tests
More informationAbstract. Introduction. Materials and methods. Patients and methods
RBMOnline - Vol 8. No 3. 344-348 Reproductive BioMedicine Online; www.rbmonline.com/article/1178 on web 20 January 2004 Article Cumulative live birth rates after transfer of cryopreserved ICSI embryos
More informationThis information explains the advice about assessment and treatment for people with fertility problems that is set out in NICE guideline CG156.
Assessment and treatment for people with fertility problems Information for the public Published: 1 February 2013 nice.org.uk About this information NICE guidelines provide advice on the care and support
More informationInformation for Recipient of Donor Oocytes
Introduction Thank you for expressing an interest as an oocyte recipient in our oocyte donation program at the Family Fertility Center. Our successful program was established since 1994 and is directed
More informationCollege of Physicians and Surgeons of Saskatchewan STANDARDS. Assisted Reproductive Technology PREAMBLE
College of Physicians and Surgeons of Saskatchewan STANDARDS Assisted Reproductive Technology STATUS: UNDER REVIEW Approved by Council: September 2012 Amended: November 2015 To be reviewed: November 2020
More informationPossibilities Plan. Access to the care you need.
Possibilities Plan If you do not have insurance or have insurance but lack coverage for infertility services and are concerned about the cost of infertility services, The Center for Advanced Reproductive
More informationWOMEN S HEALTH SERVICES
WOMEN S HEALTH SERVICES Committed to enhancing the total well-being of women throughout their lives Knowledge-Powered Medicine 877-WSU-DOCS upgdocs.org/womenshealth WOMEN S HEALTH SERVICES UPG Women s
More informationFertility Services Commissioning Policy
Fertility Services Commissioning Policy NEE CCG Policy Reference: Where patients have commenced treatment in any cycle prior to this version becoming effective, they are subject to the eligibility criteria
More informationIn Vitro Fertilization What to expect
Patient Education In Vitro Fertilization What to expect This handout describes how to prepare for and what to expect when you have in vitro fertilization. It provides written information about this process,
More informationHow to Select an Egg Donor
How to Select an Egg Donor How to Select an Egg Donor Egg donation entails the fertilization of eggs of a young woman and transfer of the resulting embryo or embryos into the intended mother uterus. In
More informationΑssisted Reproduction and the Law. presented by Theodoros Trokanas, Lecturer of Civil Law & Biolaw, School of Law European University of Cyprus
Αssisted Reproduction and the Law presented by Theodoros Trokanas, Lecturer of Civil Law & Biolaw, School of Law European University of Cyprus Human Reproduction primordial human instinct legitimate desire
More informationEmbryo Selection after IVF
Embryo Selection after IVF Embryo Selection after IVF Many of human embryos produced after in vitro fertilization carry abnormal chromosomes. Placing a chromosomally normal embryo (s) into a normal uterus
More informationChapter 7 Infertility, Contraception, and Abortion
Chapter 7 Infertility, Contraception, and Abortion Infertility Incidence Affects about 10% to 15% of reproductive-age population Subfertility: prolonged time to conceive Sterility: inability to conceive
More informationArticle Round-table multidisciplinary counselling of couples with HIV prior to assisted reproduction
RBMOnline - Vol 17. No 2. 2008 167-174 Reproductive BioMedicine Online; www.rbmonline.com/article/3256 on web 19 June 2008 Article Round-table multidisciplinary counselling of couples with HIV prior to
More informationDRAFT Policy for Assisted Conception
NHS Birmingham and Solihull Clinical Commissioning Group NHS Sandwell and West Birmingham Clinical Commissioning Group DRAFT Policy for Assisted Conception 1 Document Details: Version: DRAFT v7. Ratified
More informationPatient Overview: Invitro Fertilisation
Patient Overview: Overview IVF stands for in-vitro fertilisation i.e. literally fertilisation in a glass dish. You may also hear the term ART used which stands for Assisted Reproductive Technologies. IVF
More informationCOMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES V2.
COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES V2.3 2017 Agreed at Cannock Chase CCG Signature: Designation: Chair of
More informationPlanning for Parenthood After a Cancer Diagnosis
Cancer and Fertility Planning for Parenthood After a Cancer Diagnosis If you or someone you love is facing cancer, preserving fertility may be the last thing on your mind. But if you re a woman of childbearing
More informationIntra uterine insemination (IUI) Information for Patients and Partners
Intra uterine insemination (IUI) Information for Patients and Partners What is this leaflet about and who is it for? This leaflet is produced to inform couples undergoing IUI (intrauterine insemination)
More informationMedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: PA.018.MH Last Review Date: 08/04/2016 Effective Date: 01/01/2017
MedStar Health, Inc. POLICY AND PROCEDURE MANUAL PA.018.MH Infertility- Treatment This policy applies to the following lines of business: MedStar Employee (Select) MedStar MA DSNP CSNP (Not Covered) MedStar
More informationFertility Services Commissioning Policy
Fertility Services Commissioning Policy Author: Commissioning Team Version No: Two Policy Effective From: 29 September 2016 Review Date: September 2017 Policy Amendment: 02 August 2017 Document Reader
More informationCOMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES
COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES Version number V2.3 Responsible individual Author(s) Barry Weaver Trish
More informationInternational Federation of Fertility Societies. Global Standards of Infertility Care
International Federation of Fertility Societies Global Standards of Infertility Care Standard 8 Reducing the incidence of multiple pregnancy following treatment for infertility Name Version number Author
More information